Treatment of covid-19
OwnerJudith Bostoninventor
Life of this patent
Estimating the term…
Abstract
This disclosure relates to the use of an oxygen-containing liquid for treating a coronavirus infection, such as Covid-19.
Claims21
A method of interfering with binding of a SARS-CoV-2-Spike protein to an ACE2 receptor or reducing propagation of a SARS-CoV-2 virus, comprising administering an oxygen containing liquid to a human being, wherein the oxygen containing liquid contains an oxygenating composition that releases oxygen gas by a chemical reaction or chemical degradation.
(canceled)
A method of treating Covid-19, comprising administering an oxygen containing liquid to a human being in need thereof, wherein the oxygen containing liquid is contained within poly (lactic-co-glycolic acid) nanoparticles or microparticles, wherein the oxygen containing liquid contains an oxygenating composition that releases oxygen gas by a chemical reaction or chemical degradation.
A method of treating Covid-19 comprising administering an oxygen containing liquid to a human being in need thereof, wherein the oxygen containing liquid is prepared by dissolving or dispersing an oxygenating composition in an aqueous liquid, wherein the oxygenating composition releases oxygen gas by a chemical reaction or chemical degradation.
Dependencies are inferred from the claim text.